Role of follow-on drugs and indications of the WHO Essential Drug List

Research output: Contribution to journal › Article › Academic › peer-review

10 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	585-592
Number of pages	8
Journal	International Journal of Clinical Pharmacology and Therapeutics
Volume	31
DOIs	https://doi.org/10.1111/j.1365-2710.2006.00777.x
Publication status	Published - 2006
Externally published	Yes

Research programs

@article{a7f2e15a4b1f41c380e685e8b1c5bd98,

title = "Role of follow-on drugs and indications of the WHO Essential Drug List",

author = "Cohen, \{JP (Joshua)\} and L Cabanilla and J Sosnov",

year = "2006",

doi = "10.1111/j.1365-2710.2006.00777.x",

language = "Undefined/Unknown",

volume = "31",

pages = "585--592",

journal = "International Journal of Clinical Pharmacology and Therapeutics",

issn = "0946-1965",

publisher = "Dustri-Verlag Dr. Karl Feistle",

}

TY - JOUR

T1 - Role of follow-on drugs and indications of the WHO Essential Drug List

AU - Cohen, JP (Joshua)

AU - Cabanilla, L

AU - Sosnov, J

PY - 2006

Y1 - 2006

U2 - 10.1111/j.1365-2710.2006.00777.x

DO - 10.1111/j.1365-2710.2006.00777.x

M3 - Article

C2 - 17176363

SN - 0946-1965

VL - 31

SP - 585

EP - 592

JO - International Journal of Clinical Pharmacology and Therapeutics

JF - International Journal of Clinical Pharmacology and Therapeutics

ER -